Search Results - Claude Barberis

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Pharmacological characterization of two specific binding sites for neurohypophyseal hormones in hippocampal synaptic plasma membranes of the rat.

    Pharmacological characterization of two specific binding sites for neurohypophyseal hormones in hippocampal synaptic plasma membranes of the rat. by S. Audigier, Claude Barberis

    Published 1985
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Structural bases of vasopressin/oxytocin receptor function

    Structural bases of vasopressin/oxytocin receptor function by Claude Barberis, Bernard Mouillac, Thierry Durroux

    Published 1998
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with β-arrestin and their trafficking patterns

    Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with β-arrestin and their trafficking patterns by Sonia Terrillon, Claude Barberis, Michel Bouvier

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    A radioiodinated linear vasopressin antagonist: A ligand with high affinity and specificity for V<sub>1a</sub> receptors

    A radioiodinated linear vasopressin antagonist: A ligand with high affinity and specificity for V<sub>1a</sub> receptors by Anne Schmidt, S. Audigier, Claude Barberis, Serge Jard, M. Manning, Aleksandra S. Kołodziejczyk, W. H. Sawyer

    Published 1991
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Molecular cloning and expression of a fifth muscarinic acetylcholine receptor

    Molecular cloning and expression of a fifth muscarinic acetylcholine receptor by C F Liao, Axel P. N. Themmen, Rolf H. Joho, Claude Barberis, M Birnbaumer, Lutz Birnbaumer

    Published 1989
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The D136A mutation of the V<sub>2</sub>vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities

    The D136A mutation of the V<sub>2</sub>vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonis... by Denis Morin, Nathalie de la Cotte, Marie‐Noëlle Balestre, Bernard Mouillac, Maurice Manning, Christophe Breton, Claude Barberis

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    The Binding Site of Neuropeptide Vasopressin V1a Receptor

    The Binding Site of Neuropeptide Vasopressin V1a Receptor by Bernard Mouillac, Bice Chini, Marie‐Noëlle Balestre, Jack Elands, Susanne Trumpp-Kallmeyer, Jan Hoflack, Marcel Hibert, Serge Jard, Claude Barberis

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin

    Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin by Bice Chini, Bernard Mouillac, Marie‐Noëlle Balestre, Susanne Trumpp-Kallmeyer, Jan Hoflack, Marcel Hibert, Maria Andriolo, Sandrine Pupier, Serge Jard, Claude Barberis

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition

    Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition by Michael Lampa, Heike Arlt, Timothy He, Beatriz Muñoz, Jason Reeves, Bailin Zhang, Joshua Murtie, Gejing Deng, Claude Barberis, Dietmar Hoffmann, Hong Cheng, Jack Pollard, Christopher Winter, Victoria M. Richon, Carlos Garcia-Escheverria, Francisco Adrián, Dmitri Wiederschain, Lakshmi Srinivasan

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus

    Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus by Yahya S. Al‐Awthan, Didier Morin, Bernard Mouillac, Nancy Sabatier, R. Vargas, Nathalie de la Cotte, M Déchaux, Corinne Antignac, Marie‐Françoise Arthus, Michèle Lonergan, Michelle Turner, M N Balestre, G. Alonso, Marcel Hibert, Claude Barberis, Geoffrey N. Hendy, Daniel G. Bichet, Serge Jard

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

    Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. by C. Serradeil‐Le Gal, C Lacour, G Valette, Georges Garcia, Loïc Foulon, G Galindo, Lise Bankir, Brigitte Pouzet, Gilles Guillon, Claude Barberis, D Chicot, Serge Jard, P. Vilain, Corinne Garcia, E. Marty, Danielle Raufaste, Gabrielle Brossard, Dino Nisato, Jean‐Pierre Maffrand, G. Le Fur

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: